Diagnosis of group A streptococcal pharyngitis in the paediatric emergency department using a fluorescence-based

Ali J Alhaddad1, Salma Aljaroodi1, Omar M Alkhasawneh2

  • 1Department of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University (IAU), Dammam, Saudi Arabia.

Insights

A new fluorescence immunoassay rapid antigen diagnostic test (FIA-RADT) accurately diagnoses group A streptococcal pharyngitis in children. This point-of-care test can significantly reduce unnecessary antibiotic prescriptions.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Diagnostic Accuracy

Background:

  • Rapid antigen diagnostic tests (RADTs) for group A streptococcal (GAS) pharyngitis exhibit high specificity but variable sensitivity.
  • Local data on the diagnostic performance of novel fluorescence immunoassay RADTs (FIA-RADTs) and their impact on antibiotic prescribing patterns are lacking.

Purpose of the Study:

  • To assess the accuracy of FIA-RADTs in diagnosing GAS pharyngitis in children presenting with pharyngitis.
  • To estimate the effect of FIA-RADTs as a point-of-care test (POCT) on antibiotic prescription rates in a pediatric emergency department.

Main Methods:

  • A prospective study enrolled 246 children aged 3-14 years with pharyngitis.
  • Throat swabs were analyzed using both FIA-RADTs and throat culture; conventional PCR was used for discordant results.

Main Results:

  • FIA-RADTs demonstrated high diagnostic accuracy: 95.6% sensitivity, 96.8% specificity, 94.6% positive predictive value, and 97.4% negative predictive value.
  • Implementation of FIA-RADTs as POCT could reduce antibiotic prescriptions from 65.9% to 37.4%.
  • FIA-RADTs significantly decreased antibiotic prescribing rates for patients with clinical scores of 2 and 3 from 48.8%/60.6% to 9.5%/31.9% respectively.

Conclusions:

  • The FIA-RADT is a reliable, prompt, and user-friendly diagnostic tool for GAS pharyngitis in pediatric settings.
  • This test can aid in reducing antibiotic overprescription, particularly in low-risk children identified by clinical scoring.